Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  AMAG Pharmaceuticals, Inc.    AMAG

AMAG PHARMACEUTICALS, INC. (AMAG)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
23(c) 22.55(c) 21.8(c) 21.125(c) 21.75(c) Last
975 975 1 058 454 1 123 184 845 327 850 388 Volume
-3.36% -1.96% -3.33% -3.10% +2.96% Change
More quotes
Financials (USD)
Sales 2018 540 M
EBIT 2018 -103 M
Net income 2018 -144 M
Debt 2018 450 M
Yield 2018 -
Sales 2019 432 M
EBIT 2019 -111 M
Net income 2019 -88,2 M
Debt 2019 539 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 2,21x
EV / Sales2019 2,98x
Capitalization 747 M
More Financials
Company
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia.The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat... 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Surperformance© ratings of AMAG Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on AMAG PHARMACEUTICALS, INC.
06/20AMAG PHARMACEUTICALS : Announces Divestiture of Cord Blood Registry
AQ
06/15CALIFORNIA CRYOBANK : And Cord Blood Registry To Be Combined By GI Partners To C..
PR
06/15AMAG PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Regulati..
AQ
06/15AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry®
GL
06/13AMAG PHARMACEUTICALS, INC. : Initiating Free Research Reports on ArQule and Thre..
AC
06/13AMAG PHARMACEUTICALS : and March of Dimes Announce Collaboration to Improve Heal..
AQ
06/11AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Impro..
GL
06/08AMAG PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Submissio..
AQ
06/04AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing ..
GL
05/29AMAG Pharmaceuticals to Present at Upcoming Investor Conference
GL
More news
Sector news : Pharmaceuticals - NEC
06/22Federal Judge Gives Lilly Win on Alimta Regimen Patent
DJ
06/22JOHNSON & JOHNSON : Remakes Top Leadership -- Update
DJ
06/22JOHNSON & JOHNSON : Worldwide Chairman Peterson to Retire
DJ
06/22SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
06/22Roche to Appoint James Sabry as Head of Partnering
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/23AMAG Pharmaceuticals $AMAG Stock Rating Lowered by ValuEngine  
06/22AMAG Pharmaceuticals $AMAG Upgraded at BidaskClub  
06/18Analysis: Positioning to Benefit within The Stars Group, AMAG Pharmaceuticals.. 
06/18AMAG Pharmaceuticals $AMAG Upgraded at B. Riley  
06/18AMAG Pharmaceuticals $AMAG Cut to Neutral at Janney Montgomery Scott  
More tweets
Qtime:54
News from SeekingAlpha
06/15AMAG to divest Cord Blood Registry for $530M 
06/05Tricida readies IPO 
06/05AMAG Pharma CEO sells shares 
05/22Antares Pharma, Excellent Risk-Reward Profile 
05/21Premarket analyst action - healthcare 
Chart AMAG PHARMACEUTICALS, INC.
Duration : Period :
AMAG Pharmaceuticals, Inc. Technical Analysis Chart | AMAG | US00163U1060 | 4-Traders
Technical analysis trends AMAG PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 22,2 $
Spread / Average Target 2,2%
EPS Revisions
Managers
NameTitle
William K. Heiden President, Chief Executive Officer & Director
Gino Santini Chairman
Edward H. Myles CFO, Treasurer, Principal Accounting Officer & SVP
Julie Krop Chief Medical Officer & Executive Vice President
Robert J. Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AMAG PHARMACEUTICALS, INC.64.15%747
JOHNSON & JOHNSON-12.08%329 475
PFIZER0.22%213 568
NOVARTIS-9.42%191 991
ROCHE HOLDING LTD.-10.81%191 785
MERCK AND COMPANY9.24%165 373